Mod GRF 1-29

Modified GRF 1-29 is a truncated version of Growth Hormone-Releasing Hormone (GHRH). Unlike GHRH, Mod GRF 1-29 is not a full-length peptide but rather a shorter version containing only 29 amino acids. In Mod GRF 1-29, four of the original amino acids have been modified, to enhance its stability. These modifications serve to make the molecule more resistant to degradation by dipeptidyl peptidase-4 (DPP-4) enzymes, which would otherwise break down the peptide structure. By reducing susceptibility to enzymatic degradation, these modifications may potentially increase the peptide’s half-life and improve its pharmacokinetics.

 Mod GRF 1-29

Ipamorelin is a synthetic pentapeptide, falling under the growth hormone secretagogue receptor (GHSR) agonist category. The peptide was derived from GHRP-1, which in turn is an analog of met-enkephalin, but potentially may not possess affinity to the opioid receptors. It appears to activate the ghrelin receptors (GHSR) which appear to trigger growth hormone synthesis.

Fragment 176-191, as the name implies, is a small ‘fragment’ of the growth hormone (hGH), also referred to as the “fat-burning peptide” for its potential in that area. Fragment 176-191 peptide, composed of 16 amino acids, including the last 15 amino acids from 177 to 191 found in hGH, has tyrosine added at the N-terminus (beginning). The peptide is also known as AOD 9604.